CiToxLAB Appoints John C. Kapeghian as Senior Director of Toxicology|
Wednesday, March 19, 2014
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs.
Thermo Acquires Prionics AG
Monday, March 17, 2014
Thermo Fisher Scientific announce it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company.
Agilent Technologies Hosts Forensics e-Seminar Series: "Definitive Drug Detection"
Tuesday, March 11, 2014
Leading Forensic Experts to Discuss Designer Drugs, Drugs of Abuse, Criminalistics.
Vanderbilt Awarded $16.5M to Determine how Toxic Agents Affect Human Cells
Friday, March 07, 2014
As part of the Rapid Threat Assessment program, the team will seek to develop mass spec methods for quickly determining how potentially toxic agents affect human cells.
Distribution Agreement to Offer GlobalFiler Express Chemistry
Wednesday, February 26, 2014
Life Technologies today announced it has signed an agreement giving IntegenX Inc. the rights to distribute its GlobalFiler Express chemistry on IntegenX’s RapidHIT™ platform.
Biometrics Institute, Elsevier Partner for Biometrics 2014
Wednesday, February 19, 2014
The Biometrics Institute announce strategic partnership with Elsevier for the delivery of the Biometrics 2014 Conference & Exhibition to be held on the 21-23 October 2014 in London.
PIEZOMAT Project Targets New Fingerprint Technology
Thursday, February 13, 2014
Ultra-high resolution sensing uses vertical piezoelectric nanowire matrices to reconstruct the smallest features of human fingerprints.
NIST Presents an Infrastructure Plan to Strengthen Forensic Science Committees
Sunday, February 09, 2014
NIST forensic science experts presented a plan for a new Organization of Scientific Area Committees (OSAC) at the first meeting of the National Commission on Forensic Science in Washington, D.C.
Thermo Completes Life Tech Acquisition
Tuesday, February 04, 2014
The completion of the transaction follows the receipt of all required regulatory approvals.